Allison Schwartz
Known title: DirectorCIK: 0001924980
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 92 | $0 | 9/6/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 34 | $13K | 9/6/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 228 | $0 | 9/5/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 82 | $32K | 9/5/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 117 | $0 | 9/1/2026 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 43 | $16K | 9/1/2026 | View on chart |
| BIO | ▲ Buy | Option Exercise | 92 | $0 | 9/6/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 33 | $10K | 9/6/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 147 | $0 | 9/1/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 55 | $16K | 9/1/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 56 | $0 | 9/3/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 27 | $9K | 9/3/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 44 | $0 | 9/2/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 21 | $7K | 9/2/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 74 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 35 | $12K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 42 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 20 | $7K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 31 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 15 | $5K | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Gift | 57 | $0 | 8/26/2024 | View on chart |
| BIO | ▼ Sell | Gift | 49 | $0 | 12/5/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 82 | $0 | 9/4/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 34 | $13K | 9/4/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 56 | $0 | 9/3/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 23 | $9K | 9/3/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 44 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 18 | $7K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 41 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 17 | $7K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 30 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 12 | $5K | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Gift | 42 | $0 | 11/7/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 80 | $0 | 9/5/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 33 | $16K | 9/5/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 82 | $0 | 9/4/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 34 | $16K | 9/4/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 56 | $0 | 9/3/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 23 | $11K | 9/3/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 43 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 18 | $9K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 30 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 12 | $6K | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.